Last reviewed · How we verify
NCT06855056: PROSPECT
Validation of New Prognostic Biomarkers in Patients With Decompensated Cirrhosis
trial in Liver Cirrhosis in 189 participants. Currently enrolling.
30 March 2026
Quick facts
| Lead sponsor | European Foundation for Study of Chronic Liver Failure |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 189 |
| Start date | 1 March 2025 |
| Primary completion | 30 March 2026 |
| Estimated completion | 30 September 2026 |
| Sites | 9 locations across France, Italy, United Kingdom, Germany, Spain |
Conditions studied
- Liver Cirrhosis — all drugs for Liver Cirrhosis →
- Decompensated Cirrhosis of Liver — all drugs for Decompensated Cirrhosis of Liver →
Sponsor
European Foundation for Study of Chronic Liver Failure
Who can join
Adults 18 to 80, any sex, with Liver Cirrhosis or Decompensated Cirrhosis of Liver. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study aims to test the effectiveness of new biomarkers (measurable molecules in our body) in predicting the health outcome of patients with liver cirrhosis discharged from the hospital after a serious complication of the disease
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06855056
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Liver Cirrhosis
Currently open trials in the same condition.
- NCT07439939 — Exploration of Systemic and Portal Hemostasis in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt Place · recruiting
- NCT07325526 — A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- · Phase 2 · recruiting
- NCT07418008 — The Liver Cirrhosis Cognitive Decline Scale (LiCCoS) · recruiting
- NCT07201649 — Roles of Hepatic Insufficiency, Hepatic Fibrosis, and Inorganic Pyrophosphate in the Progression of Arterial Calcificati · NA · recruiting
- NCT07252102 — Effect of HFNC on Incidence of Hypoxia During Sedated Gastrointestinal Endoscopy in Critical Patients · NA · recruiting
Other European Foundation for Study of Chronic Liver Failure trials
Trials by the same sponsor.
- NCT04613921 — Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06855056 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by European Foundation for Study of Chronic Liver Failure
- Last refreshed: 6 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06855056.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing